Introduction This study investigated Northern Ireland Diabetic Eye Screening Programme (NIDESP) attendance and diabetic retinopathy (DR) prevalence/severity in patients with diabetes mellitus secondary to chronic pancreatitis (PwDMsCP). Research design and methods Medical/NIDESP records for all PwDMsCP attending the pancreatic diabetes clinic were analyzed in 2017 (n=78) and 2019 (n=94). Results Between 2017 and 2019, those without DR decreased (76% to 63%); mild non-proliferative DR (NPDR), severe NPDR and PDR were found in 30%, 2% and 5%, respectively (previously 18%, 4%, 2%); diabetic maculopathy (DMac) was present in 12% (previously 10%). There was no significant difference between worst-eye DR/DMac grade and HbA1c, gender, body mass index, pancreatitis etiology and screening attendance (p>0.05). Patients with proliferative DR had longer diabetes and pancreatitis duration than DR-free patients (both p=0.001). Conclusions DR prevalence was similar in PwDMsCP and patients with type 2 diabetes of similar disease duration. This work demonstrates the importance of reaching all patients for establishing DR severity reliably and to provide accessible, equitable care to PwDMsCP. Data are available upon reasonable request.

中文翻译：

---

在北爱尔兰的一组继发于慢性胰腺炎 (DMsCP) 的糖尿病患者中筛查糖尿病视网膜病变 (DR) 的出席率、患病率和严重程度

介绍 本研究调查了继发于慢性胰腺炎 (PwDMsCP) 的糖尿病患者的北爱尔兰糖尿病眼科筛查计划 (NIDESP) 出席率和糖尿病视网膜病变 (DR) 患病率/严重程度。研究设计和方法 2017 年 (n=78) 和 2019 年 (n=94) 分析了所有参加胰腺糖尿病诊所的 PwDMsCP 的医疗/NIDESP 记录。结果 2017 年至 2019 年间，没有 DR 的人数减少（76% 至 63%）；轻度非增殖性 DR (NPDR)、重度 NPDR 和 PDR 分别占 30%、2% 和 5%（以前为 18%、4%、2%）；糖尿病性黄斑病变 (DMc) 占 12%（以前为 10%）。最差眼 DR/DMc 等级与 HbA1c、性别、体重指数、胰腺炎病因和筛查出席率之间没有显着差异（p>0.05）。增殖性 DR 患者的糖尿病和胰腺炎病程比无 DR 患者更长（均 p=0.001）。结论 PwDMsCP 和病程相似的 2 型糖尿病患者的 DR 患病率相似。这项工作证明了接触所有患者以可靠地确定 DR 严重性并为 PwDMsCP 提供可及、公平的护理的重要性。可应合理要求提供数据。